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Abstract Non-invasive vascular studies can provide crucial information on the presence,
location, and severity of critical limb ischaemia (CLI), as well as the initial assessment or
treatment planning.
Ankle-brachial index with Doppler ultrasound, despite limitations in diabetic and end-
stage renal failure patients, is the ﬁrst-line evaluation of CLI. In this group of patients,
toe-brachial index measurement may better establish the diagnosis. Other non-invasive
measurements, such as segmental limb pressure, continuous-wave Doppler analysis and
pulse volume recording, are of limited accuracy. Transcutaneous oxygen pressure (TcPO2)
measurement may be of value when rest pain and ulcerations of the foot are present.
Duplex ultrasound is the most important non-invasive tool in CLI patients combining
haemodynamic evaluation with imaging modality.
Computed tomography angiography (CTA) and magnetic resonance angiography (MRA)
are the next imaging studies in the algorithm for CLI. Both CTA and MRA have been proven
effective in aiding the decision-making of clinicians and accurate planning of intervention.
The data acquired with CTA and MRA can be manipulated in a multiplanar and 3D fashion and
can offer exquisite detail. CTA results are generally equivalent to MRA, and both compare
favourably with contrast angiography. The individual use of different imaging modalities
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depends on local availability, experience, and costs. Contrast angiography represents the
gold standard, provides detailed information about arterial anatomy, and is recommended
when revascularisation is needed.
© 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
1. Non-invasive vascular laboratory tests
In patients with critical limb ischaemia (CLI) an accurate
diagnosis can be established with modern non-invasive
vascular diagnostic techniques to provide adequate infor-
mation for creation of a therapeutic plan. When required,
non-invasive physiological and anatomical data will be
supplemented by the use of more accurate imaging tech-
niques, such as computed tomography angiography (CTA) or
magnetic resonance angiography (MRA), and selective use of
lower extremity angiographic techniques.
The objectives of modern non-invasive testing of patients
with peripheral arterial disease are:
• to conﬁrm the presence of the disease
• to provide reproducible physiological data concerning
disease severity
• to document the location and haemodynamic importance
of vascular lesions
• to make a detailed plan in case intervention is needed.
These tests can be repeated over time to follow disease
progression and results of treatment.
Non-invasive assessment of patients with CLI can be
broadly grouped into three general categories of tech-
niques:
• physiologic or haemodynamic measurements
• measurements of tissue perfusion
• anatomic imaging.
Each modality has advantages, disadvantages and limita-
tions.
Non-invasive techniques assessing physiological parame-
ters of pressure and ﬂow can provide an initial assessment
of the location and severity of arterial disease. Doppler
ultrasonography and plethysmography, each with various
forms and techniques, are the two most commonly used
haemodynamic methods to evaluate patients with CLI.
Measurements of tissue perfusion include microcirculation
techniques; the most commonly employed is transcutaneous
partial pressure of oxygen (TcPO2) measurements.
Non-invasive anatomic imaging is usually based on
a combination of Doppler haemodynamic and B-mode
ultrasonography imaging and will be detailed in the
second part of this chapter (“Imaging techniques. Duplex
ultrasound”).
2. Physiological and haemodynamic
measurements (Table 1)
2.1. Doppler ultrasonography
Doppler ultrasonography is the single most important
modality in non-invasive evaluation of vascular disease
extent. Ultrasound techniques are based on the principle
that sound waves emitted from a probe are reﬂected at
the interface of two surfaces; the observation that an
ultrasound wave undergoes a frequency shift proportional
to the velocity of any moving object encountered (e.g. red
blood cells) is known as Doppler principle. Both quantitative
and qualitative measurements of ﬂow are allowed by
Doppler ultrasonography. Quantitative analyses are based
on pressure measurements and include ankle-brachial and
toe-brachial indices and segmental pressure; qualitative
measurements are based on the analysis of the shape and
morphology of Doppler waveforms.
2.1.1. Ankle-brachial index (ABI)
The single most valuable and commonly used diagnostic test
in the evaluation of peripheral arterial occlusive disease
is measurement of the ankle-to-brachial systolic blood
pressure ratio, termed ankle-brachial index (ABI). The ABI
is a simple, inexpensive, non-invasive test that can be
performed easily in most clinical settings; it is measured
with a handheld continuous-wave Doppler ultrasound probe
and a blood pressure cuff: the highest systolic pressure
measured from either the posterior tibial or dorsalis pedis
artery (in each leg) is divided by the highest brachial artery
pressure taken from either arm. Optimal recordings are
obtained with blood pressure cuffs that are appropriately
sized to the patient’s lower calf, immediately above the
ankle. Systolic pressures are recorded with a Doppler probe
after the patient has been at rest in supine position for
5 minutes. Pulse wave reﬂection in healthy individuals
causes the ankle pressure to be 10––15mmHg higher than
the brachial artery systolic pressure.2––4 If the arm blood
pressures are not equal, a subclavian/axillary stenosis or
occlusion might be present, and the arm with the highest
blood pressure is used for subsequent blood pressure ratio
calculations. In patients with ischaemic ulcers, the ankle
pressure is typically 50––70mmHg, and in patients with
ischaemic rest pain it is typically 30––50mmHg. However,
falsely high values can be recorded in CLI patients, in whom
the ABI test is not reliable due to incompressible calciﬁed
vessels as in patients with long-standing diabetes, advanced
age or end-stage renal disease.
The ABI provides objective data that serve as the ﬁrst-
line assessment for the diagnosis of lower limb vascular
disease and has been used either as a baseline diagnostic
tool for patients with CLI (foot ulcer or rest pain) or
to monitor the efﬁcacy of therapeutic interventions. The
normal range of ABI is quoted as 0.91––1.31.4,5 The cut-
off point for diagnosis of vascular disease is typically set
at 0.90 at rest.1 ABI values between 0.41 and 0.90 are
considered “mildly to moderately” diminished and an ABI
of 0.40 or less as “severely” decreased. Although it has
been suggested that patients with an ABI <0.40 are more
likely to develop ischaemic rest pain, ischaemic ulceration,
or gangrene, compared to patients with an ABI 0.5, there
is no general consensus regarding the prognostic value of
these ABI categories for peripheral disease.1,2,6––11 In diabetic
patients, Clairotte et al. reported that the cut-off values for
the highest sensitivity and speciﬁcity for vascular disease
screening were between 1.0 and 1.1.11
ABI measurement is claimed to be a simple and repro-
ducible test. Reporting standards require a change of 0.15
to be considered clinically relevant, or >0.10 if associated
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Table 1 Non-invasive physiologic vascular diagnostic techniques: advantages and limitationsa
Technique Advantages Limitations
Ankle-brachial index
(ABI)
Simple, inexpensive, quick, widely applicable,
cost-effective.
Sensitive in establish or refute CLI diagnosis.
Useful to monitor efﬁcacy of therapeutic interventions in
CLI.
May be falsely elevated in patients with diabetes,
renal insufﬁciency and advanced age.
Indirect measure.
Does not provide localisation of the disease.
Does not allow visualisation of artery lesion.
Toe-brachial index
(TBI)
Simple, inexpensive and quick.
Useful in the presence of small vessel artery disease.
Useful in non-compressible pedal arteries.
Limited accuracy.
Requires careful techniques and small cuffs (not
widely applicable).
Indirect measure.
Does not provide localisation of the disease.
Segmental pressure Useful in initial anatomical localisation of CLI disease.
Useful in creating therapeutic plan based on disease
localisation.
Provides data to predict wound healing and limb survival.
Useful to monitor efﬁcacy of therapeutic intervention.
Not accurate in non-compressible pedal arteries as
in very old patients, in diabetics and in those with
end-stage renal disease.
Does not provide direct visualisation of the disease.
Old-fashioned measure of perfusion.
Continuous-wave
Doppler ultrasound
Useful in initial evaluation of CLI anatomy, severity and
progression.
Can provide adjunctive information in incompressible
arteries.
Can provide localising information.
Can provide qualitative data to monitor after successful
revascularisation.
Limited sensitivity.
Limited speciﬁcity especially for aorto-iliac
occlusive disease.
Old-fashioned measure of perfusion.
Does not provide visualisation of the disease.
Limited overall accuracy.
Pulse volume
recording (PVR)
Initial evaluation of CLI in vascular laboratories.
Useful in non-compressible pedal arteries especially in
diabetic patients (photoplethysmography).
Useful to monitor limb perfusion after revascularisation.
Old-fashioned technique affected by subjectivity
(waveforms interpretation).
Qualitative and not quantitative measure of
perfusion.
Limited accuracy.
May be abnormal in low cardiac stroke volume.
Does not provide localisation or visualisation of the
disease.
CLI, critical limb ischaemia.
a Adapted from Hirsch et al.1
with a change in clinical status. Well-controlled, repeated
measurements are accurate enough to be used as a clinical
indicator in decision-making. However the reproducibility
may vary among experienced physicians.5,7,8,12,13 It has been
shown that the reproducibility of ABI assessment by pocket
Doppler may be dependent on the level of experience of the
operator.6,14––17 Inter-observer variability among experienced
physicians has a reported k-statistic of 0.77 to 1.0.5
Intra-observer variability ranges from 7.3% to 12%.5,7,8,12,13
Holland-Letz and Endres and colleagues18,19 found small
intra- (8%) and inter-observer errors (0––9%) among different
practitioner groups in large unselected populations.
Different modes of determination and calculation of the
ABI can be applied especially in primary care practices.6
Klein and Hage found 39 different ways to calculate the
ABI.20 Nicolai et al., investigating the use of ABI in non-
specialist settings, showed that eight different methods
were commonly used for calculation of the ABI in primary
care practices.6 A recently published literature analysis that
evaluated the methodology of ABI determination in 100
random publications demonstrated great variability with
respect to the methods of ankle and brachial blood pressure
measurements as well as calculation of the index.21 Major
international societies2,4 recommend calculating the ABI by
dividing the highest pressure in the leg by the highest
pressure in the arm to guarantee good reproducibility. Use
of a standardised step-by-step technique for measuring ABI
is required for reproducibility of measurements.
ABI has been largely validated against contrast-enhanced
angiography to determine obstructions greater than 50%. The
ABI has been reported to be 95% sensitive and 99% speciﬁc
for peripheral disease detection when a 0.9 cut-off level
from measurements is used.22––25 In general, the sensitivity
of ABI ranges from 80% to 95% and the speciﬁcity from
95% to 100%, with positive and negative predictive values
in excess of 90%.1,5,6,22 However, as pointed out by Al-
Qaisi et al. in a recent update on ankle-brachial index
(2009 review), the majority of authors quoting detection
accuracy for ABI normal/abnormal ranges refer back to
original data from pioneering works performed in the 1970s
and 1980s.5,26––31
The diagnostic accuracy of ABI as a screening test
may be limited in diabetic patients, especially those with
nephropathy, foot lesions and old age, probably due to the
high prevalence of medial arterial calciﬁcations causing a
high prevalence of false negative values. Sensitivity ranging
from 63% to 100% and speciﬁcity values of 85––97% have
been reported in these patients.7,32––36 In a recent study
analysing patients undergoing both ABI and angiography
measurements, Chung et al. showed that the most signiﬁcant
factor affecting the validity of ABI was diabetes (OR 4.36
for false-negative results).37 Although CLI is very common in
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diabetic patients (prevalence of vascular disease estimated
around 13.6% vs. 4% in the general population),7,38 it often
remains under-recognised in this population.7,39 Diagnosis
is often difﬁcult because the co-existence of peripheral
neuropathy could mask the ischaemic pain. In these settings
sensitivity in detecting vascular disease of ABI ranges from
50% to 71% and speciﬁcity from 30% to 96.8%.7,11,34,40––42
The ABI is relatively insensitive for determining progres-
sion of lower limb occlusive disease when compared to
arteriography or duplex ultrasonography. McLafferty et al.
found an ABI sensitivity of 41%, speciﬁcity of 84%, positive
predictive value of 59% and overall accuracy of 68% in
detecting disease progression.43
In addition to its use in evaluating symptomatic patients
affected by peripheral vascular disease, decreased ABI is
a strong predictor of cardiovascular events and premature
mortality.44––47 An ABI <0.90 is associated with a 3- to 6-fold
increased risk of cardiovascular mortality.45––48 A meta-
analysis in 2008 by Fowkes et al.49 found that abnormal
ABI was associated with approximately twice the 10-year
total mortality, cardiovascular mortality, and major coronary
event rate compared with the overall rate in each Framing-
ham risk score category. The American Diabetes Association
recommends screening for ABI in all diabetic patients aged
>50 years, as well as in younger insulin-dependent patients
with other vascular risk factors.35,45,47,50,51 ABI measurement
can be used as a prognostic index to facilitate initiation
of treatment (hypertension, dyslipidaemia, diabetes, etc.)
to reduce cardiovascular events and should be routinely
performed in patients aged 70 years, with rest pain or
ulcers, and those with a history of diabetes or smoking.47
Although the ABI has gained widespread acceptance as
a single, accurate and reproducible ﬁrst-line method to
evaluate arterial occlusive disease and a valid cardiovascular
prognostic instrument, the test has deﬁnite limitations and
it should be associated with duplex ultrasound imaging.
Summary messages (advantages and limitations of ABI):
• ABI can be useful as a routine measurement in primary
care practices providing objective and reproducible ﬁrst-
line assessment of CLI. It is sensitive and speciﬁc in the
differential diagnosis of leg symptoms to identify or rule
out a vascular aetiology.
• ABI measurement is a widely applicable, simple, quick,
cost-effective and non-invasive tool to establish or dis-
prove the baseline for CLI and to follow revascularisation
results.
• ABI can provide objective data that serve as the standard in
ofﬁce practice, vascular laboratories and epidemiological
surveys.
• ABI provides indirect information on arterial disease but
cannot localise the anatomical level of a pressure-reducing
obstruction.
• The reproducibility of ABI measurements is dependent on
the level of experience of the operator and may vary
among experienced physicians, university hospitals and in
community settings.
• ABI may not be accurate in the presence of incompressible
lower extremity arteries as occurs in very elderly
individuals, diabetics, or patients with long-standing renal
disease.
• Use of a standardised step-by-step technique for measuring
ABI is required to ensure reproducibility of measure-
ments.
Recommendations
The resting ABI is useful in the initial evaluation for CLI
and can be easily and quickly measured on both legs to
conﬁrm diagnosis and establish the severity of disease in
patients with rest leg/foot symptoms as well as individuals
with foot non-healing ulcer and lower limb rest pain.
(Level 2b; Grade B)
The resting ABI in all new patients with CLI can be used
to establish the baseline to evaluate the effect after
revascularisation procedures. (Level 2b; Grade B)
ABI is less reliable in CLI diagnosis in patients with
incompressible arteries (long-standing diabetes, end-stage
renal disease, advanced age) and should be supported
by more reliable techniques in these settings. (Level 2b;
Grade B)
2.1.2. Toe-brachial index
Since the presence of CLI is higher in patients with diabetes
and end-stage renal disease, this may preclude accurate
assessment of ABI in most subsets of these patients.7,38
Incompressible arteries are suggested when the ABI is
greater than 1.3. The digital vessels are usually spared
from calciﬁcation; therefore, toe systolic blood pressures
are often more accurate in quantifying vascular disease
in diabetic, dialysis-dependent or very old patients. Toe
pressures are obtained by placing small occlusive cuffs
around each toe (usually at the proximal portion of digit
I and II) with a digital ﬂow sensor beyond the cuff. Toe
systolic pressure can be expressed as a ratio of the toe
pressure to the highest pressure recorded in either arm to
obtain the toe-brachial index (TBI).
Normally the toe pressure is approximately 30mmHg less
than the ankle pressure and TBI should be >0.75. Values <0.7
are considered abnormal and TBI <0.25 is consistent
with severe CLI.52,53 Absolute toe pressures <30mmHg are
required to diagnose CLI in patients with rest pain.2 For
patients with ulcers or gangrene, the presence of CLI is
diagnosed by toe systolic pressure <50mmHg. Absolute toe
pressure of 55mmHg or greater has been correlated to
be predictive for foot ulcer healing in diabetic patients,
and TASC requires toe pressure <50mmHg (critical level) to
conﬁrm CLI diagnosis in diabetic patients.2
Toe pressure measurements were shown to be more
reliable than ABI measurements in patients with diabetes
associated with falsely high ABI values and peripheral
neuropathy.34,54,55 Brooks et al. compared TBI and ABI
in 174 diabetics and 53 controls and found comparable
indices when ABI was low or normal (84% and 78%
agreement, respectively), but not when ABI was elevated.54
In the presence of clinical peripheral neuropathy, toe
pressure sensitivity has been evaluated to be 100% and ABI
sensitivity 53%.34
However, TBI measurement requires appropriate tech-
nique and tools (small cuffs), therefore it is not widely
applicable and the overall accuracy may be limited.
Furthermore, it may be impossible to measure toe pressures
in patients with inﬂammatory lesions, ulceration or loss of
tissue.
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Summary messages (advantages and limitations of toe-
brachial index):
• Toe-brachial index is a quick way to non-invasively
establish or disprove the CLI diagnosis in patients with
lower limb rest pain or non-healing ulcers.
• Toe-brachial measurements are particularly useful in
individuals with incompressible crural and pedal arteries.
• The test requires small cuffs and a careful technique to
preserve accuracy.
Recommendation
Toe-brachial index is useful to establish CLI diagnosis in
patients in whom CLI is clinically suspected (non-healing
ulcer, rest pain) but the ABI test is not reliable due
to incompressible vessels as in patients with diabetes,
advanced age or long-standing renal failure. (Level 2b;
Grade B)
2.1.3. Segmental limb pressure
The location and extent of CLI can be indirectly deﬁned
in a non-invasive laboratory by segmental limb systolic
pressure measurements, recorded with a Doppler instrument
and blood pressure cuffs placed over the brachial arteries
and sequentially at various points on the lower limbs,
including the upper and lower thigh, the upper calf, the
ankle, and metatarsal. Theoretically, the cuff width should
be 20% greater than the diameter of the limb at the
point where it is applied. Narrow cuffs may be associated
with the appearance of falsely high pressures and do not
permit accurate disease localisation.1,2 The examination
is performed by placing a Doppler probe over the most
prominent arterial signal at the ankle with the patient in
supine position. In most laboratories a 20mmHg gradient
between adjacent segment cuffs is regarded as indicative
of a signiﬁcant occlusive lesion. Thus, by comparing the
pressures obtained at different levels, segmental pressure
measurement can detect the location of arterial occlusive
lesions with reasonable accuracy. Segmental pressure
measurements can provide information in patients with
multi-level disease and predict ulcer healing, limb survival
or the need for further additional revascularisation.54––56
However, as already stated by the TASC II and AHA
Guidelines,1,2 there are a number of limitations and
potential problems in the analysis of segmental limb
pressure that render it an old-fashioned diagnostic technique
for CLI evaluation.
• Isolated moderate stenosis (usually iliac) that produces
little pressure gradient may be missed.
• Calciﬁed arteries may lead to falsely elevated ankle
pressures.
• In patients with multi-level disease, decreased proximal
pressures may mask more distal gradients.
• Segmental pressure gradients are not suitable to differen-
tiate between short- and long-segment lesions or between
highly stenotic arteries and occlusions.
• Reduced thigh pressure is usually indicative of a pressure-
reducing obstruction along the aorto-iliac axis; however,
similar ﬁndings may be produced by an obstruction of the
common femoral or proximal superﬁcial femoral and deep
femoral arteries.
• Artefacts on measurements due to inappropriate cuff
size/position are common.
Summary messages (advantages and limitations of seg-
mental limb pressure):
• Segmental pressure can provide ﬁrst-line information on
anatomical localisation of lower limb vascular disease in
patients with CLI.
• Segmental pressure measurement can be helpful to
establish more sophisticated imaging techniques to
determine a detailed localisation of the disease.
• The test may not be accurate in the presence of
incompressible arteries.
• Measurements of segmental pressure can provide only
indirect information on vascular disease and results can
be biased by a number of artefacts and drawbacks. The
test should not be used as the sole diagnostic technique
but should be associated with ultrasound imaging.
Recommendation
Lower limb segmental pressure measurements can provide
a ﬁrst-line localisation of arterial lesion along lower limb in
patients with CLI. Segmental pressure should not be used
as the sole diagnostic technique. (Level 2b; Grade B)
2.1.4. Continuous-wave Doppler ultrasound
Quantitative and qualitative analysis performed by continu-
ous-wave Doppler ultrasound remains an old-fashioned
technique which is no longer routinely used in many
modern diagnostic vascular laboratories. The AHA guidelines
recognise that Doppler waveforms analysis needs to be
combined with ultrasound visualisation of arterial vessel
(“duplex imaging”) to maximise the beneﬁts of this
technique.1
Analysis of morphology of the continuous-wave Doppler
waveform was suggested to provide useful information in
localising and quantifying vascular disease in patients with
poorly compressible arteries. Many patients with diabetes
or end-stage renal disease, without palpable pulses and
monophasic Doppler signals, may have an ABI greater
than 1.0, which is a deceptive and misleading quantitative
assessment of the severity of vascular disease.57
The most commonly used “pulsatility index” is deﬁned
as the peak systolic velocity (or “frequency shift”) divided
by the mean blood ﬂow velocity. Normally, the pulsatility
index increases from the most proximal to the most distal
segments of the lower extremities; a decrease between
adjacent segments implies the presence of occlusive disease
between these two locations.57,58
However, reversion to a normal waveform below a
proximal stenosis may often occur. This phenomenon of
“pulse normalisation” distal to some arterial stenosis is a
recognised major diagnostic limitation of the technique that
may occur especially in the presence of multi-level disease
with high-resistance ﬂow.
Furthermore, quantitative assessment of the pulsatility
index is weakened in the presence of arterial calciﬁcations.
Currently, the beneﬁts of continuous Doppler waveform
analysis are limited, and it should always be combined with
ultrasound greyscale or colour visualisation of the arterial
wall. Such “duplex imaging” represents one of the most
widely used non-invasive vascular laboratory techniques
replacing the traditional continuous-wave Doppler velocity
analysis.
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Summary messages (advantages and limitations of
continuous-wave Doppler ultrasound):
• Continuous-wave Doppler ultrasound can be used as
an initial step to indirectly assess lower limb vascular
disease. The test enables indirect qualitative evaluation
of blood ﬂow, vessel localisation and ﬂow detection
in nonpalpable arteries, and quantitative systolic blood
pressure measurements along lower limb vessels.
• Continuous-wave Doppler ultrasound does not provide
visualisation of vessel anatomy.
• Continuous-wave Doppler ultrasound is limited in accuracy
and is relatively insensitive especially for iliac arterial
disease detection. “Pulse normalisation” downstream from
stenosis can diminish test sensitivity.
• Continuous Doppler waveform should be combined with
other imaging (ultrasound greyscale or colour visualisation
of the arterial wall: “duplex ultrasound imaging”).
• Continuous-wave Doppler ultrasound remains an old-
fashioned technique no longer routinely used in many
modern laboratories.
Recommendations
Continuous-wave Doppler ultrasound is of limited use in
providing initial qualitative and quantitative assessment
of lower limb vascular disease location and severity, and
in following outcomes of vascular disease with or without
revascularisation. (Level 3b; Grade C)
Since continuous Doppler ultrasound does not allow direct
arterial visualisation, this test should always be combined
with real imaging through ultrasound greyscale or colour
visualisation of the arterial wall (“duplex ultrasound
imaging”). (Level 2c; Grade B)
2.2. Plethysmography
Plethysmography in CLI evaluation has been introduced in
the past to detect changes in limb volume by “pulse volume
recording” (PVR) which produces recordings that are similar
to continuous Doppler waveforms.59,60
However, the lack of reliable, reproducible quantitative
data limits the utility of plethysmography for diagnosis
or arterial disease and CLI in most modern vascular
laboratories today. With more widespread utilisation of
ultrasound methods, the use of plethysmography has
declined substantially.
The main value of PVR waveform analysis may be that it
is not affected by medial calciﬁcation and therefore it is
relatively useful in the diabetic population.61
Accuracy of PVR and photoplethysmography has been
tested against Doppler ultrasound in several studies,56,62,63
indicating that the techniques might be useful in diabetic
patients with CLI, including those with oedema, but the
method may have poor accuracy in vascular diseases located
in distal limb segments.64
PVR tracings at the foot level have been used as an
indicator of healing potential for foot wound or amputation
procedures.8,45,56,65,66
Limitations of PVR include that it may be a rather
subjective tool for evaluation of CLI since measurements
are based on subjective waveform analysis. PVR may be
abnormal in patients with low cardiac stroke volume and
overall accuracy is limited. Although quantitative criteria
have been proposed in PVR, they are not widely used
clinically owing to limited accuracy.1
Summary messages (advantages and limitations of pulse
volume recording):
• PVR remains an old-fashioned technique no longer
routinely used in many modern laboratories.
• PVR may be useful as an initial diagnostic test for patients
with foot pain or ulcers and suspected CLI, to assess limb
perfusion and predict risk of amputation in CLI patients.
• PVR can provide a tool to evaluate individuals with
incompressible vessels in whom ABI and segmental
pressures are spuriously elevated.
• PVR does not allow reliable quantitative measure of
perfusion and may not be accurate.
• PVR may be abnormal in patients with low cardiac stroke
volume.
• PVR in evaluation of limb perfusion is affected by
“subjective inﬂuence” and is less accurate than other non-
invasive tests in providing arterial anatomical localisation
of disease.
• Although PVR may be useful and cost-effective as a
baseline tool in ofﬁce practice or vascular laboratories,
other non-invasive techniques can today provide more
quantitative and accurate information on perfusion and
anatomical localisation of lower limb disease in CLI.
Recommendations
Pulse volume recording may be used as an initial step in
the evaluation of patients with foot pain and ulcer and
suspected CLI and can be applied to establish diagnosis,
assess localisation or severity of the disease and follow
status of revascularisation procedures, but accuracy is
limited. (Level 3b; Grade C)
Pulse volume recording may be applied to establish the
initial lower limb CLI diagnosis in diabetic patients and
patients with incompressible arteries, but it should be
combined with additional tests (e.g., “duplex ultrasound
imaging”). (Level 2a; Grade B)
Advantages and limitations of each non-invasive physio-
logical and haemodynamic diagnostic test are summarised
in Table 1.
3. Measurements of tissue perfusion
Different non-invasive measurements of tissue perfusion
have been used to assess the severity of lower limb
ischaemia. The applicability and reliability are generally
limited with respect to Doppler ultrasonography.
Measurements of transcutaneous oxygen pressure (TcPO2)
reﬂect the metabolic state of lower limbs with CLI and
diabetic feet. Small electrodes consisting of a circular
silver––silver chloride anode surrounding a central platinum
cathode are placed on the skin; oxygen diffusing to the
surface of the skin is reduced at the cathode to produce
a current proportional to the partial pressure of oxygen
(PO2) within the sensor. In patients with foot ulcers,
tissue loss or rest pain, TcPO2 values can be used to
assess the presence and severity of vascular disease, the
need for revascularisation, and to predict the success
of healing with or without revascularisation. This test is
performed by placing probes with electrodes on the foot
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and the leg, using the chest as a reference site. Common
locations for assessment are the dorsum of the foot, the
anteromedial aspect of the calf 10 cm below the knee,
and the thigh 10 cm above the knee. Normal TcPO2 values
depend on age (higher for younger) and position (higher for
proximal). Normal TcPO2 levels are approximately 60mmHg,
while levels of 20mmHg or less strongly suggest that
revascularisation will be required to achieve healing. TASC II
requires a critical level of TcPO2 <30mmHg to conﬁrm
diagnosis of CLI in patients with non-healing foot ulcers or
diabetic foot.2
Measurement of TcPO2 is most helpful for evaluating cases
of severe limb ischaemia, while it is relatively insensitive
to mild or moderate degrees of peripheral vascular disease
because the oxygen supply to the skin is far greater than
the demand. TcPO2 measurements combined with clinical
determination may be of value to predict healing at
various levels of amputation, especially in diabetic patients,
because it is not affected by arterial calciﬁcation.67––69
Nevertheless, measurements of TcPO2 must be interpreted
cautiously, since the test is often unreliable because it
is affected by many factors that are difﬁcult to control,
including skin temperature, sympathetic tone, cellulitis,
hyperkeratosis, obesity, oedema, metabolic activity, oxygen
diffusion through tissue, age, vertical position of the site
of measurements. In addition, when values are low, TcPO2
is not linearly related to ﬂow: a value of zero does not
mean that there is no ﬂow to the area of interest; rather it
indicates that all the available oxygen has been consumed.
Therefore, TcPO2 is not routinely used in most vascular
laboratories.
Measurement of skin perfusion pressure (SPP) is another
microcirculatory assessment tool that can be utilised to
assess foot healing potential.70 SPP is measured with laser
Doppler and represents the blood pressure required to
restore microcirculatory or capillary ﬂow after inducing
controlled occlusion and return of ﬂow. The ability of this
test to predict amputation healing is not as good as that
of TcPO2 measurements. Normal pressures of 50––70mmHg
are decreased to 10––20mmHg in limbs with severe limb
ischaemia. Pressures below 30mmHg are predictive of CLI.
Laser Doppler is not widely used in vascular laboratories,
mainly because of an inability to calibrate the instrument
to actual levels of blood ﬂow and the availability of more
accurate, direct methods for assessing CLI.
Hyperspectral tissue oxygenation measurements have also
been used to predict healing of diabetic foot ulcers. The test
should identify microvascular abnormalities in the diabetic
foot, but this technology is currently being utilised mainly
as a research tool.71
Summary messages (advantages and limitations of tissue
perfusion measurements):
• Tissue perfusion measurement can be useful to assess the
severity of lower limb ischaemia.
• These techniques can be used in monitoring and/or re-
evaluating patients following endovascular or surgical
revascularisation.
• Microcirculatory assessment of perfusion can be utilised to
assess wound healing potential.
• Transcutaneous oxygen pressure (TcPO2) is valuable to
examine the metabolic state of the target tissue.
• Measurements of TcPO2 are time-consuming and may
be unreliable because inﬂuenced by many physiological,
methodological and technical factors (skin temperature,
sympathetic tone, cellulitis, hyperkeratosis, obesity,
oedema, metabolic activity, oxygen diffusion through
tissue, age, etc.).
• TcPO2 could not be measured in advanced CLI because
of intolerable pain during the examination in the supine
position.
Recommendations
Patients with ischaemic rest pain or foot ulcers can be
investigated with objective tests of tissue perfusion to
conﬁrm diagnosis of CLI. (Level 2a; Grade B)
These may include TcPO2, laser Doppler and hyperspectral
measurements to assess metabolic state of tissue
perfusion. (Level 3b; Grade C)
Tissue perfusion tests (TcPO2, laser Doppler, spectral
imaging) can be used to assess healing potential of ul-
cers/amputation in patients with CLI (Level 3b; Grade C ––
Level 4; Grade D)
4. Imaging techniques
The purpose of vascular imaging for patients with CLI is to
assess the anatomical location, morphology and extent of
disease to determine suitability for open or endovascular
revascularisation. Major technical advances have been
accomplished in recent years in the development of non-
invasive imaging modalities. Today, the following options for
imaging are available:
• duplex ultrasound (DUS)
• magnetic resonance angiography (MRA)
• computed tomography angiography (CTA)
• digital subtraction angiography (DSA).
The main characteristics of these imaging modalities,
including their principal advantages and disadvantages, are
summarised in Table 2.
4.1. Duplex ultrasound
Duplex ultrasound (DUS) enables identiﬁcation of the
anatomical location and the degree of stenosis in lower
extremity peripheral arterial disease (PAD) by combining
both B-mode ultrasound and colour Doppler ultrasound.
Haemodynamic assessment is performed by measuring peak
systolic velocity (PSV) and PSV ratios within or beyond an
obstruction compared with the adjacent upstream segment,
the presence or absence of turbulence, and preservation
of pulsatility. A PSV ratio of greater than 2:1 is considered
to indicate a >50% stenosis, a PSV ratio greater than 4:1
a >75% stenosis and a PSV ratio of greater than 7:1 a
>90% stenosis.74
Accuracy of DUS: Several studies have reported a high
accuracy of DUS in comparison with DSA. A recent meta-
analysis of studies published between 1996 and 2005
produced a pooled sensitivity of 88% (84––91%) and a
pooled speciﬁcity of 94% (93––96%) for DUS, conﬁrming data
from a former meta-analysis75––77 (Table 3). When used by
experienced operators and in suitable patients, DUS can
produce a map of signiﬁcant obstructive disease from the
abdominal aorta to the feet.78
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Table 2 Comparison of different imaging modalities for patients with PADa
DUS CTA MRA Angiography
Availability +++ ++ ++ +++
Appointment time (minutes) 40+ (both
legs)
15 30 30
Equipment cost + ++ +++ +++
Operator expertise +++ + ++ ++
Arteriographic map Yes, by
experienced
operators
Yes (requires
post-processing)
Yes (immediately available) Yes (immediately
available)
Diagnostic accuracy
Aorto-iliac ++ +++ +++ +++
Femoro-popliteal +++ +++ +++ +++
tibial + + ++ +++
Stent assessment ++ + Steel: poor
Nitinol: fair
+++
Limitations by vascular calciﬁcation ++ ++ None Almost none
Complications and risks
Access site None None None Rare
Ionising radiation exposure None 7.5––13.7mSv None Higher than CTA
Contrast-enhanced nephropathy None ++ Extremely rare ++
Nephrogenic systemic ﬁbrosis None None Very rare None
Allergic reaction None Rare Very rare Rare
Contraindications None Severe renal
impairment,
known allergy to
contrast agents
Cerebrovascular clips, electronic
implants (infusion or monitoring
devices, neurostimulation
devices), pace-makers,
cardioverter-deﬁbrillators,
claustrophobia
Severe renal
impairment, known
allergy to contrast
agents
CTA, computed tomography angiography; DUS, duplex ultrasound; MRA, magnetic resonance angiography; mSv, millisievert;
PAD, peripheral arterial disease.
a Modiﬁed from Norgren et al.,2 Owen and Roditi72 and Kramer et al.73
DUS can be used for pre-intervention decision-making
by predicting whether a patient has anatomy suitable
for femoro-popliteal angioplasty with an accuracy of
84––94%.81,82 It has also been used as a substitute for
DSA for infrainguinal bypass grafting to select the most
appropriate tibial vessel for distal anastomosis, although
some studies have suggested that DUS alone is inferior to DSA
for evaluation of tibial arteries for distal bypass surgery.83––90
Another study has demonstrated no difference in patency
of infrapopliteal bypass grafts in non-randomised cohorts of
patients evaluated by pre-operative DUS vs. angiographic
methods.85
DUS can also be used for post-revascularisation surveil-
lance of venous and prosthetic grafts. Venous grafts may
fail due to de novo obstructions either within the body of
the graft or at the anastomoses (intimal hyperplasia), or
due to progression of atherosclerotic obstructions upstream
or downstream from the graft. DUS surveillance studies can
detect these obstructions during impeding graft thrombosis
with greater sensitivity than evaluation by clinical history,
physical examination, or use of the resting ABI.1,91––96 In
general, low velocities indicate poor arterial inﬂow, proximal
stenosis, or large graft diameter. One study showed that
presence of a PSV less than 45 cm/s within a graft indicates
that subsequent graft failure is likely to occur.97,98 Another
study found that vein grafts that were revised on the basis
of positive DUS ﬁndings had a 90% 1-year patency rate,
similar to grafts with initially normal duplex examinations.
Grafts that were not revised despite the presence of a DUS-
detected stenosis had a patency rate of only 66% at 1 year.92
Unfortunately, three RCTs offered conﬂicting results, with a
3-year primary assisted patency rate of vein grafts monitored
with DUS of 78% vs. 53% for those followed up clinically
and with the ABI in one study and no improved patency
in the others.99,100 The Vein Graft Surveillance Randomised
Trial (VGST)101 assessed the beneﬁts of DUS compared with
clinical vein graft surveillance in terms of amputation rates,
quality of life and healthcare costs in patients after femoro-
popliteal and femorocrural vein bypass grafts. A total of 594
patients with a patent vein graft at 30 days after surgery
were randomised to either a clinical or a duplex follow-up
programme at 6 weeks, then 3, 6, 9, 12, and 18 months
post-operatively. Both groups had similar amputation rates
(7% for each group) and vascular mortality rates (3% vs. 4%)
over 18 months. More patients in the clinical group had
vein graft stenoses at 18 months (19% vs. 12%, p = 0.04),
but primary patency, primary assisted patency and secondary
patency rates, respectively, were similar in the clinical group
(69%, 76% and 80%) and the duplex group (67%, 76% and 79%).
There were no apparent differences in health-related quality
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Table 3 Systematic reviews and meta-analyses to assess the diagnostic accuracy of duplex ultrasound (DUS), magnetic resonance
angiography (MRA) and computed tomography angiography (CTA) in the detection of >50% stenosis or occlusion in patients with
peripheral arterial disease (PAD)
Reference Modality Characteristics Anatomical
region
Pooled
sensitivity
Pooled
speciﬁcity
Visser, 200078 Contrast-
enhanced
MRA
• 9 studies (1990––1998) with a total of 216 pts (11––30)
• CLI in only 3 studies, in 2 studies no clinical data)
Whole leg 98%
(96––99%)
96%
(94––98%)
DUS • 18 studies (1984––1998) with a total of 1059 pts (12––167)
• CLI in 9 studies (10––84% of the study population), in 7
studies no clinical data
Whole leg 88%
(84––91%)
95%
(93––96%)
Collins et al.,
200776,77
DUS • 7 studies (1996––2005) with a total of 369 pts (20––76)
• 134––3108 segments per study (median 404 segments)
• CLI in about 10% (range 0––19%) of pts
Whole leg 88%
(80––98%)
96%
(89––99%)
2D time-of-
ﬂight MRA
• 5 studies (1996––2005) with a total of 287 pts (20––155)
• 206––1188 segments/study (median 378 segments)
• CLI in 82––100% of pts (no clinical data in 3 studies)
Whole leg 92%
(79––94%)
88%
(74––92%)
Contrast-
enhanced
MRA
• 7 studies (1996––2005) with a total of 279 pts (20––76)
• 418––1780 segments/study (median 520 segments)
• CLI in 0––92% of pts (no data in 3 studies)
Whole leg 95%
(92––100%)
97%
(64––99%)
Menke et al.,
201079
Contrast-
enhanced
MRA
• 32 studies (2004––2009) with a total of 1022 pts (10––76)
• 120––1780 segments per study (median 384 segments)
• 24% of all investigated arterial segments had stenoses or
occlusions
• CLI in 26% (range 0––100%) of pts
Aorto-iliac
Femoro-
popliteal
Tibial
94%
(91––96%)
95%
(91––98%)
92%
(90––94%)
96%
(94––97%)
96%
(95––98%)
93%
(90––96%)
Met et al.,
200980
CTA • 20 studies (1966––2008) with a total of 957 pts (16––279)
• 167––4743 segments per study (median 730 segments)
• 29% of all investigated arterial segments had stenoses or
occlusions
• CLI in <20% (range 0––100%) of all pts (68% IC, 10––20% no
data)
Aorto-iliac
Femoro-
popliteal
Tibial
96%
(91––99%)
97%
(95––99%)
95%
(85––99%)
98%
(95––99%)
94%
(85––99%)
91%
(79––97%)
of life, but the average health service costs incurred by the
DUS surveillance programme were greater by £495 (95%CI
£83––807) per patient. The authors concluded that intensive
surveillance with DUS did not show any additional beneﬁt
in terms of limb salvage rates for patients undergoing
vein bypass graft operations, but it did incur additional
costs.101 In a further prospective study, a normal DUS scan
6 weeks subsequent to infrainguinal vein bypass grafting was
associated with a 40-month cumulative patency rate of 82%,
indicating that further DUS surveillance in these patients is
not beneﬁcial.102 There is an ongoing transatlantic discussion
whether or not DUS surveillance is beneﬁcial in patients with
infrainguinal venous bypass grafting, with a tendency for
routine DUS in these patients in North America,103––105 while
the situation in Europe remains equivocal.102,106,107
DUS surveillance of synthetic grafts is of questionable
value. Several studies have found no improvement in
patency of grafts, whereas other studies have successfully
detected stenoses and found some improvement in patency.
This lack of evidence may be due to DUS-associated technical
challenges (inability to visualise the stenosis, vascular
anatomic challenges) or procedural challenges, such that the
subsequent graft revision does not help to improve long-term
graft patency.1,100,101,108––111
DUS surveillance after angioplasty (PTA) procedures
is also of questionable value. Immediately after PTA,
several studies suggested that velocities in the treated
segment may be abnormally elevated and do not predict
decreased subsequent patency rates. This may be due
to angioplasty-induced vessel dissections that successfully
remodel over time. DUS is useful in evaluations for recurrent
obstructions.1,112––119 Although it is reasonable to assume
that revisions of post-PTA restenoses that are detected by
DUS studies might improve patency, there are no published
studies conﬁrming this approach on a high evidence level.1
Summary messages: Advantages and disadvantages of
duplex ultrasound:
• DUS is non-invasive, relatively inexpensive and as an
outpatient procedure well tolerated by patients.
• DUS can also be performed in emergency situations on the
ward or in the operating theatre.
• There are limitations to the visualisation of iliac vessels
in the pelvis (due to body habitus and bowel gas),
very distal arteries and collaterals. In addition, extensive
calciﬁcation may produce incomplete examinations and in
patients in whom multi-level PAD downstream stenoses are
detected the sensitivity is decreased, perhaps owing to
slow ﬂow.120,121
• The technique is highly operator-dependent and proper
training is mandatory.98
• Since the vast majority of DUS studies were performed
in mixed populations, the validity of DUS imaging for
CLI patients alone is still uncertain.
• No side effects or adverse events have been reported.
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Table 4 Recommendations in current guidelines for duplex ultrasound imaging in patients with CLI
Grade of
recommendation
Level of
evidence
Duplex ultrasound of the extremities is useful to diagnose anatomical location and degree of
obstruction in PAD patients a.
A 1a
Duplex ultrasound may be considered for routine surveillance after femoropopliteal or
femorotibial-pedal venous bypass grafts a.
B 2b
Duplex ultrasound of the extremities can be useful to select patients as candidates for endovascular
interventiona.
B 2b
Duplex ultrasound may be useful to select patients as candidates for surgical bypass and to select the
sites of surgical anastomosis a.
B 2b
Duplex ultrasound may be considered for routine surveillance after femoropopliteal bypass with a
synthetic conduit a.
B 3b
The use of duplex ultrasound is not well established to assess long-term patency of percutaneous
transluminal angioplastya.
B 3b
CLI, critical limb ischaemia; PAD, peripheral arterial disease.
a Adapted from Hirsch et al.1
Recommendations in current guidelines (Table 4)
The current ACC/AHA Practice guidelines for PAD patients
give a strong recommendation that DUS is useful
to diagnose the anatomical location and degree of
obstruction of PAD. (Level 1a; Grade A)
Despite the discrepancies mentioned above, DUS surveil-
lance of venous grafts is also recommended with regular
follow-up intervals (3, 6, 12 months, and then yearly after
graft placement).1 (Level 2b; Grade B)
The guidelines for non-invasive vascular laboratory testing
from the American Society of Echocardiography and the
Society for Vascular Medicine and Biology recommend
DUS evaluation of the graft twice during the ﬁrst post-
operative year, and annually thereafter.98 The ACC/AHA
guidelines consider DUS also as useful to select patients
as candidates for endovascular intervention or surgical
bypass (Grade B) and state that DUS may also be
considered for routine surveillance after femoropopliteal
bypass with a synthetic graft (Level 2b; Grade B).
Finally, DUS is not well established to assess long-term
patency of PTA.1 (Level 2b; Grade B)
Critical issues
• The majority of DUS studies are more than 10 years
old. New studies should consider following the STARD
guidelines for reporting of diagnostic accuracy studies and
should also consider reporting results by patient or by
limb, as well as by segment.122––124
• Future reviews should make use of the QUADAS as a quality
assessment tool speciﬁcally developed for systematic
reviews of diagnostic accuracy studies.125
• Further research should consider comparing DUS directly
with MRA and/or CTA as the reference standard.
• The value of the operative or endovascular correction
of DUS-detected post-PTA lesions has to be evaluated in
further studies.
• Future studies should identify patients with infrainguinal
vein or prosthetic bypasses, who beneﬁt from a
standardised DUS surveillance programme.
• The validity of DUS imaging for patients with CLI needs to
be evaluated in patient cohorts suffering from rest pain
or non-healing ischaemic lesions in the foot.
4.2. Computed tomography angiography
Computed tomography angiography (CTA) is increasingly
attractive due to rapid technical developments. Shorter ac-
quisition times, thinner slices, higher spatial resolution, and
improvement of multidetector computed tomographic (CT)
scanners enable scanning of the entire vascular tree in a
limited period with a decreasing amount of contrast medium
and radiation burden.
Accuracy of CTA: In a recent meta-analysis, 20 studies
published between 1966 and 2008 (957 patients) were
reviewed systematically by use of the QUADAS checklist.126
Between 167 and 4743 arterial segments were analysed in
each study (median 730 segments) and 29% of all segments
had stenoses or occlusions. Slice thickness varied between
0.75 and 5.0mm (median 2.0mm). Various contrast media
were used for the CTA (Iomeprol in 6 studies, iopromide
in 4 studies, and the remaining studies used other iodine-
based contrast media). The iodine concentration varied
between 300 and 400mg/mL. The amount of contrast
volume administered per scan varied between 88 and 170mL
(median 130mL). Interpretation of CTA was always based on
the axial images. Other image reconstructions used were
maximum-intensity projections (n = 17), volume-rendering
technique (n = 15), multiplanar reformation (n = 6), curved-
planar reformation (n = 4), and virtual endoscopy (n = 1). The
pooled sensitivity to detect a >50% stenosis or occlusion
was 95% (92––97%) and the pooled speciﬁcity 96% (93––97%).
CTA correctly identiﬁed occlusions in 94% of segments, the
presence of >50% stenosis in 87% of segments, and absence of
signiﬁcant stenosis in 96% of segments. Overstaging occurred
in 8% of segments and understaging in 15%. The data included
trials of CTA vs. DSA across three different generations of
CT technology (i.e., scanners with 4, 16, and 64 detector
rows) and with technological advancement there has
been a corresponding improvement in diagnostic accuracy
(sensitivity and speciﬁcity has increased from 75––99% and
83––99% with 4 detector rows to 98––99% and 96––99% for
64 detector rows). Diagnostic accuracy was lower for smaller
arteries compared with proximal lesions, but the diagnostic
performance below the knee remains good (sensitivity
85––99%, speciﬁcity 79––97%) (Table 3). Inter-observer agree-
ment is good to excellent (k values >0.8) in most studies.126
The great majority of patients in trials of peripheral arterial
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Table 5 Recommendations in current guidelines for CT angiography imaging in patients with CLI
Grade of
recommendation
Level of
evidence
CTA of the extremities may be considered to diagnose anatomic location and presence of signiﬁcant
stenosis in patients with lower extremity PADa.
B 3a
CTA of the extremities may be considered as a substitute for MRA for those patients with
contraindications to MRAa.
B 3a
Patients with baseline renal insufﬁciency should receive hydration before undergoing CTAa. A 2b
CLI, critical limb ischaemia; CTA, computed tomography angiography; MRA, magnetic resonance angiography; PAD, peripheral arterial
disease.
a Adapted from Hirsch et al.1
imaging are claudicants and there are limited data in pa-
tients with CLI. In a recent study of 28 patients with CLI who
were evaluated with 16-detector-row CTA, 23 had treatment
plans conﬁdently formulated on the basis of the CTA alone.
Side effects/adverse events: The average radiation dose
reported in the CTA literature is 7.47mSv,127 although aver-
age doses as high as 13.7mSv have been reported in some
series.128 In a trial of 16-detector-row CTA vs. DSA, Willmann
et al. reported a four-fold higher radiation dose for DSA
compared with CTA.129 To place these doses in context, the
average annual background radiation exposure is between
2 and 3mSv.80 It has been suggested that patient radiation
dose issues are of limited concern in patients with advanced
PAD, as their life expectancy is signiﬁcantly less than the
latent period of a radiation-induced malignancy.130 The late
effects of radiation exposure are more important in younger
patients, however; physicians should be aware of this issue
and strive to keep dosing as low as reasonably possible.
Iodinated contrast agents are associated with an increased
risk for contrast-induced nephropathy (CIN), deﬁned as an
increase in serum creatinine level >25% or >0.5mg/dL above
baseline within 3 days of contrast administration in
the absence of other causes.73,131 Patients who are
considered at highest risk are those with baseline renal
insufﬁciency, especially those with concomitant diabetes
mellitus. Other risk factors for CIN include multiple
myeloma, proteinuria, concomitant nephrotoxic drug use,
hypertension, congestive heart failure, hyperuricaemia, and
dehydration. The risk of CIN is dose-dependent and is
higher when contrast is administered intra-arterially than
when given intravenously.132 A systematic review revealed an
overall risk of CIN in high-risk patients of 16.8%,132 although
the clinical implications for the development of CIN are not
fully understood. Only a minority go on to require renal
replacement therapy (<1%), but in a retrospective review
of over 16,000 inpatients exposed to contrast media, in-
hospital mortality rates were ﬁve-fold higher (34% vs. 7%)
among patients who developed CIN, even after adjustment
for comorbidity.133 High-osmolar contrast puts patients with
pre-existing renal impairment at twice as high a risk of
developing CIN as low-osmolar contrast.127 However, in a
review from 2004 it was concluded that all patients with
pre-existing renal insufﬁciency were at higher risk for CIN,
no matter what type of contrast was used.134 To prevent
CIN pre-emptive hydration is recommended, especially for
those patients with renal insufﬁciency. The optimal type,
route, volume, and timing of hydration are not well deﬁned.1
Likewise, given the ability of angiotensin-converting enzyme
inhibitors and angiotensin receptor antagonists to induce
efferent arteriole vasodilatation, these medications should
be withheld the morning of contrast exposure and restarted
after monitoring of normal renal function. Administration of
antioxidants, such as mannitol, advocated as renoprotective
agents, is not supported by evidence.
Further information is provided by the European Society
of Urogenital Radiology (http://www.esur.org).
Summary messages: Advantages and disadvantages of
computed tomography angiography:
• CTA in comparison to MRA offers better patient
acceptance, a higher speed of examination, a better
spatial resolution, and the ability to evaluate previously
stented arteries. It is mostly applicable in patients with
contraindications for MRA (Table 5).
• Disadvantages of CTA include image interference from
calciﬁed arteries and the need for potentially nephrotoxic
contrast agents and radiation exposure.80
Recommendations from other guidelines (Table 5):
The current ACC/AHA Practice Guidelines give a moderate
recommendation for CTA of the extremities to diagnose
anatomic location and presence of signiﬁcant stenosis in
patients with lower extremity PAD. (Level 2B; Grade B)
In addition, CTA of the extremities may be considered
as a substitute for MRA for those patients with
contraindications to MRA.2 (Level 2B; Grade B)
TASC II stated that DUS, MRA and CTA are suitable for
decision-making. The individual use may depend on local
availability, experience, and costs.1 (Level 2B; Grade B)
Critical issues
• Patients with CLI who require a complete assessment of
their lower extremity arteries for planning an open or
endovascular intervention are under-represented in the
current studies. More research is needed to determine the
clinical value of CTA in the CLI target population.80
• CTA assessment of aorto-iliac and femoral lesions seems
to be sufﬁcient for decision planning, whereas this may
not be the case for smaller calciﬁed arteries.
• Speciﬁcity is probably overestimated due to the fact that
all studies divided the vascular tree into segments with a
relatively high proportion of segments without a signiﬁcant
stenosis (segments that are likely to be correctly identiﬁed
by CTA). From a clinical standpoint, it is more useful to
divide the vascular tree into clinically relevant segments
(eg, aorto-iliac, femoropopliteal, and distal runoff).
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• The statistical power of the available meta-analyses is
limited by the relatively small sample size of most
included studies. Larger studies are needed.
• New CTA studies should consider to follow the STARD
guidelines for reporting of diagnostic accuracy studies and
should also consider reporting results by patient or by
limb, as well as by segment.123––125
• Future reviews should make use of the QUADAS as a quality
assessment tool speciﬁcally developed for systematic
reviews of diagnostic accuracy studies.126
4.3. Magnetic resonance angiography
There have been major technical advances in recent
years including 3D contrast enhanced magnetic resonance
angiography (ce-MRA) and the development of moving
tabletops which enable whole limb examinations with a
single contrast injection.
Accuracy of MRA: A number of meta-analyses and
systematic reviews support the diagnostic accuracy of
MRA when compared to DSA.78,135,136 Two meta-analyses
determined that 3D ce-MRA is superior to 2D time-of-ﬂight
MRA.123,137 The meta-analysis by Collins et al.123 detected a
pooled sensitivity of 95% (92––100%) and a pooled speciﬁcity
of 97% (64––99%) for MRA which was superior to CTA and
DUS when compared separately to DSA. There was no
direct comparison between MRA and DUS in any of the
studies.78,123 A well-conducted systematic review concluded
that MRA is also cost-effective in comparison to DSA
when both are available locally.137 The most recent meta-
analysis included 32 studies published between 1998 and
2009 (120––1780 segments per study, median 384 segments,
altogether 1022 patients, 26% with CLI). The pooled
sensitivity of MRA was 95% (92––96%) and the speciﬁcity
was 96% (94––97%) for diagnosing segmental stenosis >50%
or occlusions. The accuracy for tibial lesions was slightly
worse compared to aorto-iliac and femoropopliteal lesions
(Table 3). MRA correctly classiﬁed 95.3%, overstaged 3.1%,
and understaged 1.6% of arterial segments.138 Some studies
claim that MRA is superior to DSA in the detection of outﬂow
vessels suitable for distal bypass in patients with CLI.79,139
Kreitner et al. found that in 24 diabetic patients with
CLI, 38% had pedal vessels detected by MRA that were not
detected by catheter angiography.139 Such vessels treated
with surgical bypass may enjoy satisfactory patency.140
The claim that MRA is more sensitive than DSA for distal
vessels is controversial and is affected by the quality of
the comparative catheter angiogram.141 At least one study
has shown MRA to be inferior to catheter angiography,
particularly for patients with CLI.142 However, other studies
have demonstrated agreement between pre-operative plans
based on MRA vs. DSA of at least 90%, and many centres no
longer perform DSA before revascularisation.
MRA has been used anecdotally for the assessment of
surgical and endovascular revascularisation. Several series
of small numbers of patients have shown that the sensitivity
and speciﬁcity of MRA compared with catheter angiography
for detection of stenoses in vein or synthetic bypass
grafts is 90––100%.143––146 For immediate post-procedural
evaluation of angioplasty sites, agreement with catheter
angiography is 80––95%.147,148 There have been no published
studies that validate improved patient outcomes from post-
revascularisation MRA surveillance.
Side effects/adverse events: Gadolinium-enhanced MRA
avoids radiation and gadolinium chelates cause anaphylactic
reactions less often than iodinated contrast medium (<1% of
all patients).149 The US Food and Drug Administration has
recommended that patients not receive gadolinium-based
contrast agents if they have acute or chronic severe renal
insufﬁciency (glomerular ﬁltration rate <30mL/min per 1.73
m2) or renal dysfunction due to the hepatorenal syndrome,
or are in the peri-operative liver transplantation period,
because of the risk for nephrogenic systemic ﬁbrosis (NSF).150
Apart from other factors, this risk seems to depend on the
stability and the dose of the applied gadolinium chelates.
However, most patients with PAD do not belong to these
risk groups and do not have a speciﬁc risk for NSF according
to current knowledge.
Summary messages: Advantages and disadvantages of
magnetic resonance angiography
• MRA, in comparison with DSA and CTA, eliminates exposure
to ionising radiation and there is no risk of CIN when
gadolinium is used in recommended doses.
• Unlike DUS and CTA, MRA is unaffected by arterial
calciﬁcation.
• MRA is performed as a fast non-invasive outpatient
procedure (<15 minutes).
• Three-dimensional images of the entire arterial tree are
presented in a maximum intensity projection format
produced on a workstation.
• Relative disadvantages include a tendency to overestimate
stenosis. Venous contamination can obscure arteries below
the knee. Claustrophobia and the presence of metallic
implants (such as pacemakers) or foreign bodies may
preclude the examination or produce artefacts.
• MRA tends to overestimate the degree of stenosis because
of turbulence and metal clips can cause artefacts that
mimic vessel occlusions. Similarly, some metal stents will
obscure vascular ﬂow.151
• Patients with pacemakers and deﬁbrillators and some
cerebral aneurysm clips cannot be scanned safely.147,152
Recommendations from other guidelines (Table 6):
The current ACC/AHA Practice Guidelines give a strong
recommendation for MRA to diagnose anatomical location
and presence of signiﬁcant stenosis in patients with
lower extremity PAD. (Level 1a; Grade A) In addition,
strong recommendations are given to perform MRA with
gadolinium enhancement (Level 1a; Grade A) and to
use MRA in selecting patients with lower extremity PAD
as candidates for endovascular intervention. (Level 1a;
Grade A)
The ACC/AHA gives moderate recommendations for MRA
as a suitable tool to select the sites of surgical
anastomosis for surgical bypass and to consider MRA for
postrevascularisation (endovascular and surgical bypass)
surveillance in patients with lower extremity PAD.1
(Level 2b; Grade B)
The Scottish Guideline also gives a strong recommendation
that non-invasive imaging modalities should be employed
in the ﬁrst instance for patients with intermittent
claudication in whom intervention is being considered. No
recommendation is given for patients with CLI.153
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Table 6 Recommendations in current guidelines for MR angiography imaging in patients with CLI
Grade of
recommendation
Level of
evidence
MRA of the extremities is useful to diagnose anatomic location and degree of stenosis of PAD and to
select patients for endovascular or open surgical interventiona.
A 1a
MRA of the extremities should be performed with gadolinium enhancementa. A 2a
MRA of the extremities is useful in selecting patients with lower extremity PAD as candidates for
endovascular interventiona.
A 2a
MRA of the extremities may be considered for post-revascularisation (endovascular and surgical
bypass) surveillance in patients with lower extremity PADa.
B 3b
CLI, critical limb ischaemia; MRA, magnetic resonance angiography; PAD, peripheral arterial disease.
a Adapted from Hirsch et al.1
Critical issues
• Patients with CLI who require a complete assessment of
their lower extremity arteries for planning an open or
endovascular intervention are under-investigated in the
current studies. More research is needed to determine the
clinical value of ce-MRA in the CLI target population.79
• Speciﬁcity is probably overestimated due to the fact that
all studies divided the vascular tree into segments with a
relatively high proportion of segments without a signiﬁcant
stenosis (segments that are likely to be correctly identiﬁed
by MRA). From a clinical standpoint, it is more useful to
divide the vascular tree into clinically relevant segments
(e.g. aorto-iliac, femoropopliteal, and distal runoff).
• The statistical power of the available meta-analyses is
limited by the relatively small sample size of most
included studies. Larger studies are needed.
• New MRA studies should consider to follow the STARD
guidelines for reporting of diagnostic accuracy studies and
should also consider reporting results by patient or by
limb, as well as by segment.123––125
• Future MRA reviews should make use of the QUADAS
as a quality assessment tool speciﬁcally developed for
systematic reviews of diagnostic accuracy studies.126
4.4. Intra-arterial angiography
Digital subtraction angiography (DSA) has been the tra-
ditional ﬁrst-line imaging investigation for patients with
PAD for many years and, although it is a two-dimensional
technique, is still considered the gold standard against which
other techniques are compared.
Accuracy of DSA: Angiography served as reference tool
for new non-invasive diagnostic tools, such as DUS, MRA
and CTA. Even though non-invasive modalities are used
as ﬁrst-line diagnostic methods for patients with PAD by
many physicians, DSA is still the only universally accepted
method for guiding percutaneous peripheral interventional
procedures.
Even though DSA is still considered to be the gold standard,
there are a number of ﬂaws:1,154
• It may not be possible to determine haemodynamic
signiﬁcance even with multiple projections.
• It may overestimate the length of occlusions.
• It may not always demonstrate patent crural vessels.
• Eccentric lesions are sometimes difﬁcult to quantify; axial
imaging techniques (e.g., MRA and CTA) may offer an
advantage for visualising these pathologies, because these
techniques offer a 3D view.
Side effects/adverse events: Although it has been
estimated that 1.7% of complications may be severe,
improvements in catheter and guidewire technology have
reduced their incidence signiﬁcantly.154,155 According to the
TASC II Consensus, angiography carries an approximately
0.1% risk of severe reaction to contrast medium, a 0.7% risk
of complications severe enough to alter patient manage-
ment, and 0.16% mortality risk and signiﬁcant expense.2
Contrast agents are also associated with a small but
important incidence of nephrotoxicity. Patients who are at
increased risk of contrast nephropathy include those with
severe baseline renal dysfunction, diabetes, low cardiac
output state, or dehydration. Recent studies have suggested
that use of low-osmolar contrast agents (e.g. iodixanol)
may reduce the incidence of renal compromise.156––159 In
patients who are high risk for nephrotoxicity, data suggest
that vigorous hydration before administration of contrast
may serve as the most important strategy to prevent
post-procedural deterioration in renal function. Because
the occurrence of nephrotoxicity appears to be dose-
dependent, it is also important to minimise contrast usage.
This dose minimisation can be accomplished by using
DSA techniques and placing catheters close to the site to
be imaged (selective angiography). The dose––nephrotoxicity
relationship is complex and cannot be calculated precisely.
Preliminary data suggest that nephrotoxicity might be
further minimised by use of preprocedural haemoﬁltration in
individuals with chronic renal failure (deﬁned as a creatinine
level >2.0mg/dL).160
The procedure involves exposure to ionising radiation and
short-stay recovery facilities. Other complications include
arterial dissection, atheroemboli and access site compli-
cations (e.g. pseudoaneurysm, arteriovenous ﬁstula and
haematoma). These problems have been greatly mitigated
by technological improvements in the procedure, including
the use of non-ionic contrast agents, DSA, intra-arterial
pressure measurements across a stenosis with and without
vasodilator (signiﬁcance peak systolic difference 5––10mmHg
pre-vasodilatation and 10––15mmHg post-vasodilatation),
and more sophisticated image projection and retention.
Alternatively, carbon dioxide and magnetic resonance
contrast agents (e.g. gadolinium) can be used instead
of conventional contrast media. In high-risk (e.g. renal
impairment) patients, restriction to a partial study with
selected views rather than visualising the entire infrarenal
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Table 7 Recommendations in current guidelines for catheter angiography in patients with CLI
Grade of
recommendation
Level of
evidence
DSA is not recommended as the primary imaging modality for patients with PADa. A 1a
Contrast angiography provides detailed information about arterial anatomy and is recommended for
evaluation of patients with lower extremity PAD when revascularisation is contemplated.
A 2a
A history of contrast reaction should be documented before the performance of contrast angiography
and appropriate pretreatment administered before contrast is givenb. The opportunity to replace DSA
with MRA could be considered.
A 2a
Decisions regarding the potential utility of invasive therapeutic interventions (percutaneous or
surgical) in patients with lower extremity PAD should be made with a complete anatomic assessment
of the affected arterial territory, including imaging of the occlusive lesion, as well as arterial inﬂow
and outﬂow with angiography or a combination of angiography and non-invasive vascular techniquesb.
A 2a
DSA is recommended for contrast angiographic studies because this technique allows for enhanced
imaging capabilities compared with conventional unsubtracted contrast angiographyb.
A 2a
Before performance of contrast angiography, a full history and complete vascular examination should
be performed to optimise decisions regarding the access site, as well as to minimise contrast dose and
catheter manipulationb.
A 3b
Selective or superselective catheter placement during lower extremity angiography is indicated
because this can enhance imaging, reduce contrast dose, and improve sensitivity and speciﬁcity of the
procedureb.
A 2b
The diagnostic lower extremity arteriogram should image the iliac, femoral, and tibial bifurcations in
proﬁle without vessel overlapb.
A 2b
When conducting a diagnostic lower extremity arteriogram in which the signiﬁcance of an obstructive
lesion is ambiguous, transstenotic pressure gradients and supplementary angulated views should be
obtainedb.
A 2b
Patients with baseline renal insufﬁciency should receive hydration before undergoing contrast
angiographyb.
A 2b
Follow-up clinical evaluation, including a physical examination and measurement of renal function,
is recommended within 2 weeks after contrast angiography to detect the presence of delayed
adverse effects, such as atheroembolism, deterioration in renal function, or access site injury (e.g.,
pseudoaneurysm or arteriovenous ﬁstula) b.
A 3a
Non-invasive imaging modalities, including MRA, CTA, and colour ﬂow duplex imaging may be used
in advance of invasive imaging to develop an individualised diagnostic strategic plan, including
assistance in selection of access sites, identiﬁcation of signiﬁcant lesions, and determination of the
need for invasive evaluationb.
A 2a
CLI, critical limb ischaemia; CTA, computed tomography angiography; DSA, digital subtraction angiography; MRA, magnetic resonance
angiography; PAD, peripheral arterial disease.
a Adapted from Hessel et al.154
b Adapted from Hirsch et al.1
arterial tree has decreased the contrast load, length of study
and associated risks. Despite this, full angiography, with
visualisation from the level of the renal arteries to the pedal
arteries using DSA techniques, remains the choice in most
cases.
Summary messages: Advantages and disadvantages of
digital subtraction angiography
• DSA provides a complete arterial map of the lower
limb circulation that is easily interpretable. Images are
easily displayed and interpreted by the vast majority of
physicians caring for patients with PAD.
• Pressure gradients can be measured to determine
haemodynamic signiﬁcance and it can be used to guide
endovascular intervention.
• Disadvantages include complications of catheterisation
which may occur both within the vessel and at the
puncture site.
Recommendations from other guidelines (Table 7):
The current ACC/AHA Practice Guidelines give the
following Grade A recommendations:
(1) DSA provides detailed information about arterial
anatomy and is recommended for evaluation of
patients with lower extremity PAD when revasculari-
sation is contemplated. (Level 2b; Grade B)
(2) A history of contrast reaction should be documented
before the performance of contrast angiography
and appropriate pretreatment administered before
contrast is given. (Level 2b; Grade B)
(3) Decisions regarding the potential utility of invasive
therapeutic interventions (percutaneous or surgical)
in patients with lower extremity PAD should be
made with a complete anatomic assessment of the
affected arterial territory, including imaging of the
occlusive lesion, as well as arterial inﬂow and outﬂow
with angiography or a combination of angiography
and non-invasive vascular techniques. (Level 2b;
Grade B)
continued on next page
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Recommendations from other guidelines (cont’d):
(4) DSA is recommended for contrast angiographic
studies because this technique allows for enhanced
imaging capabilities compared with conventional
unsubtracted contrast angiography. (Level 1a;
Grade A)
(5) Before performance of contrast angiography, a full
history and complete vascular examination should
be performed to optimise decisions regarding the
access site, as well as to minimise contrast dose and
catheter manipulation. (Level 3b; Grade C)
(6) Selective or superselective catheter placement
during lower extremity angiography is indicated since
this can enhance imaging, reduce contrast dose, and
improve sensitivity and speciﬁcity of the procedure.
(Level 3b; Grade C)
(7) The diagnostic lower extremity arteriogram should
image the iliac, femoral, and tibial bifurcations in
proﬁle without vessel overlap. (Level 2b; Grade B)
(8) When conducting a diagnostic lower extremity
arteriogram in which the signiﬁcance of an ob-
structive lesion is ambiguous, trans-stenotic pressure
gradients and supplementary angulated views should
be obtained. (Level 2b; Grade B)
(9) Patients with baseline renal insufﬁciency should
receive hydration before undergoing contrast angiog-
raphy. (Level 2b; Grade B)
(10) Follow-up clinical evaluation, including a physical
examination and measurement of renal function,
is recommended within 2 weeks after contrast
angiography to detect the presence of delayed
adverse effects, such as atheroembolism, deterio-
ration in renal function, or access site injury (e.g.,
pseudoaneurysm or arteriovenous ﬁstula). (Level 3b;
Grade C)
The ACC/AHA also suggests that non-invasive imaging
modalities, including MRA, CTA, and colour ﬂow duplex
imaging, may be used in advance of invasive imaging to
develop an individualised diagnostic strategic plan, includ-
ing assistance in selection of access sites, identiﬁcation
of signiﬁcant lesions, and determination of the need for
invasive evaluation. (Level 2b; Grade B)
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